68Ga-DOTA-GPFAPI-04

N/A

Report date: 2025/10/30 15:24:39
NME

Base Information

Drug Name68Ga-DOTA-GPFAPI-04
Drug Alias Name[68Ga]Ga-DOTA-GPFAPI-0468Ga-GPFAPI-04
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionFibroblast activation protein alpha binders
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A